Nearwater Capital Markets’s Avidity Biosciences RNAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-360,200
Closed -$26M 127
2025
Q4
$26M Buy
+360,200
New +$23.3M 0.44% 51

Other funds holding RNAM

Nearwater Capital Markets's RNAM Position: Q1 2026 in Review

Nearwater Capital Markets sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 360,200 shares — an estimated $26M sold.

Nearwater Capital Markets first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $26M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Nearwater Capital Markets reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Nearwater Capital Markets sold 360,200 Avidity Biosciences shares in Q1 2026, an estimated $26M.
  • Nearwater Capital Markets first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • Nearwater Capital Markets's Avidity Biosciences position peaked at $26M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Nearwater Capital Markets's 13F filing for Q1 2026, filed 15 May 2026.